- Steering decision making by terminology(2022)
Authors: Petr Szturz, Jan Vermorken
Pages: 587 - 591
- Prognostic implications of cellular senescence in resected non-small cell lung cancer(2022)
Authors: Christophe Deben, Ines De Pauw, Christophe Hermans, Hilde Lambrechts, Jasper Verswyvel, Vasiliki Siozopoulou, Patrick Pauwels, Marco Demaria, Mick van de Wiel, Jeroen Hendriks, et al.
Pages: 1526 - 1539
- Targeting angiogenesis in squamous cell carcinoma of the head and neck(2022)
Authors: Nabil F. Saba, Pooja Vijayvargiya, Jan Vermorken, Juan P. Rodrigo, Stefan M. Willems, Nina Zidar, Remco de Bree, Antti Maekitie, Greg T. Wolf, Athanassios Argiris, et al.
- Measurement of sarcopenia in head and neck cancer patients and its association with frailty(2022)
Authors: Remco de Bree, Christiaan D.A. Meerkerk, Gyorgy B. Halmos, Antti A. Maekitie, Akihiro Homma, Juan P. Rodrigo, Fernando Lopez, Robert P. Takes, Jan Vermorken, Alfio Ferlito
Pages: 1 - 12
- Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature(2022)
Authors: M. Opdam, V. van der Noort, M. Kleijn, A. Glas, I. Mandjes, S. Kleiterp, F.S. Hilbers, D.T. Kruger, A.D. Bins, P C. de Jong, et al.
Pages: 265 - 278
- ESO-ESSO-ESTRO multidisciplinary course in oncology for medical students(2022)
Authors: Nicholas Pavlidis, Radoslaw Madry, Marc Peeters, Sergio Sandrucci, Janina Markowska, Fedro Peccatori, Alberto Costa, Jesper Grau Eriksen, Umberto Ricardi, Richard Poetter, et al.
Pages: 1239 - 1244
- The prognostic impact of the immune signature in head and neck squamous cell carcinoma(2022)
Authors: Hasan Baysal, Vasiliki Siozopoulou, Hannah Zaryouh, Christophe Hermans, Ho Wa Lau, Hilde Lambrechts, Erik Fransen, Ines De Pauw, Julie Jacobs, Marc Peeters, et al.
Pages: 1 - 18
- Recent insights in the PI3K/Akt pathway as a promising therapeutic target in combination with EGFR-targeting agents to treat head and neck squamous cell carcinoma(2022)
Authors: Hannah Zaryouh, Ines De Pauw, Hasan Baysal, Marc Peeters, Jan Vermorken, An Wouters
Pages: 112 - 155
- Oligometastatic cancer(2021)
Authors: Petr Szturz, Jan Vermorken
- Revisiting EXTREME in the immuno-oncology era(2021)
Authors: Petr Szturz, Jan Vermorken
Pages: 899 - 901